After COVID vaccines, time to use mRNA tech against other infectious diseases

March 12, 2022

After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.

But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "

There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.

Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.

From Your Site Articles

Strategic abroad, shaky at home: Friedrich Merz’s first 100 days

Friedrich Merz, leader of the conservative Christian Democratic Union (CDU) party, gives a statement after German Chancellor Olaf Scholz sacked Finance Minister Christian Lindner, before a session of the Bundestag, Germany's lower house of parliament, in Berlin, Germany, November 7, 2024.

Reuters/Liesa Johannssen

After COVID vaccines, time to use mRNA tech against other infectious diseases

GZEROMEDIA

More from GZERO Media

Trump and Putin to meet in Alaska to discuss Ukraine

In this episode of Ian Bremmer’s Quick Take, Ian discusses the upcoming meeting between Trump and Putin in Alaska.

What We’re Watching: Trump to meet Putin in Alaska, Mali’s military arrests own soldiers, China arrests US-friendly diplomat

Hard Numbers: Colombian presidential candidate dies after June shooting, Al Jazeera journalists killed in Gaza, South Korean military dropoff, Chinese ship hits its own man

Graphic Truth: US government to get 15% of chip sales to China

In a first-of-its-kind deal, Nvidia and AMD will hand 15% of revenues from AI chip sales to China over to the US government in exchange for export licenses.

Strategic abroad, shaky at home: Friedrich Merz’s first 100 days

Friedrich Merz’s first 100 days as chancellor of Germany have marked an assertive shift in the country’s role on the European and global stage.

GZEROMEDIA

Feldman: Trump is using antisemitism to go after Harvard

Harvard Law professor Noah Feldman discusses rising antisemitism—and what he sees as the Trump administration’s weaponization of it to attack higher education.

As Trump pressures universities, what's really at stake?

As Trump targets elite universities with lawsuits and funding cut threats, Harvard law professor Noah Feldman warns that critical scientific research— not to mention the pursuit of truth itself—may be on the line.

Trump vs higher education, with Harvard's Noah Feldman

Harvard Law's Noah Feldman unpacks the Trump administration’s legal and political escalations with elite US universities.

Deadline for Putin

It has passed very strongly. #PUPPETREGIME

Iran’s next act?

Twelve days of war earlier this summer demonstrated that Iran has little capacity to defend its cities or its nuclear facilities from Israeli and US strikes. But it still likely retains some uranium supplies, so it has options.

After COVID vaccines, time to use mRNA tech against other infectious diseases

GZEROMEDIA

Subscribe to GZERO Media's newsletter: Signal

More from GZERO Media

In this episode of Ian Bremmer’s Quick Take, Ian discusses the upcoming meeting between Trump and Putin in Alaska.

In a first-of-its-kind deal, Nvidia and AMD will hand 15% of revenues from AI chip sales to China over to the US government in exchange for export licenses.

Friedrich Merz’s first 100 days as chancellor of Germany have marked an assertive shift in the country’s role on the European and global stage.

GZEROMEDIA

Subscribe to GZERO Media's newsletter: Signal

Harvard Law professor Noah Feldman discusses rising antisemitism—and what he sees as the Trump administration’s weaponization of it to attack higher education.

As Trump targets elite universities with lawsuits and funding cut threats, Harvard law professor Noah Feldman warns that critical scientific research— not to mention the pursuit of truth itself—may be on the line.

Harvard Law's Noah Feldman unpacks the Trump administration’s legal and political escalations with elite US universities.

It has passed very strongly. #PUPPETREGIME

Twelve days of war earlier this summer demonstrated that Iran has little capacity to defend its cities or its nuclear facilities from Israeli and US strikes. But it still likely retains some uranium supplies, so it has options.